Canadian Pharmacists Journal最新文献

{"title":"Why are we limiting access to opioid agonist therapies?","authors":"Jaris Swidrovich","doi":"10.1177/1715163519852973","DOIUrl":"https://doi.org/10.1177/1715163519852973","url":null,"abstract":"","PeriodicalId":46612,"journal":{"name":"Canadian Pharmacists Journal","volume":"152 1","pages":"221 - 222"},"PeriodicalIF":1.5,"publicationDate":"2019-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1715163519852973","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44315899","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Lessons learned from 3 attempts to use data sources to evaluate pharmacist prescribing in Ontario","authors":"Lisa M. McCarthy, Elizabeth A. Bojarski, N. Waite, L. Dolovich","doi":"10.1177/1715163519852975","DOIUrl":"https://doi.org/10.1177/1715163519852975","url":null,"abstract":"","PeriodicalId":46612,"journal":{"name":"Canadian Pharmacists Journal","volume":"152 1","pages":"234 - 240"},"PeriodicalIF":1.5,"publicationDate":"2019-06-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1715163519852975","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"43179449","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Pharmacists’ lack of profession-hood: Professional identity formation and its implications for practice","authors":"P. Gregory, Z. Austin","doi":"10.1177/1715163519846534","DOIUrl":"https://doi.org/10.1177/1715163519846534","url":null,"abstract":"Background: Understanding the internalized, psychological sense of being a professional may provide important insight into understanding pharmacists’ behaviours and attitudes in practice. Methods: It is difficult to directly or quantitatively measure an internalized psychological state such as profession-hood. An indirect method was selected in which pharmacists who were themselves patients or caregivers were identified and invited to discuss their experiences, as a vehicle for better understanding how they relied upon personal and professional identities during high-stress, impactful times. Results: A total of 17 community pharmacists from southern Ontario participated in this study. Regardless of demographic background, participants reported little reliance on professional identity, knowledge or role as a pharmacist when advocating for themselves or a loved one. Interpretation: These findings suggest that community pharmacists have incomplete, separated or functional (rather than existential) professional identities. This lack of professional identity may influence behaviours in practice such as interactions with other health care professionals or patients or self-confidence in clinical decision-making. Conclusions: Further work is necessary to better understand the socialization and professional identity formation of pharmacists to help support them through the current evolution of pharmacy towards more interdependent and complex clinical roles and decision-making.","PeriodicalId":46612,"journal":{"name":"Canadian Pharmacists Journal","volume":"152 1","pages":"251 - 256"},"PeriodicalIF":1.5,"publicationDate":"2019-05-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1715163519846534","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41427405","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Pharmacy Practice Research Abstracts: Canadian Pharmacists Conference 2018","authors":"","doi":"10.1177/1715163518797716","DOIUrl":"https://doi.org/10.1177/1715163518797716","url":null,"abstract":"","PeriodicalId":46612,"journal":{"name":"Canadian Pharmacists Journal","volume":"151 1","pages":"S1 - S34"},"PeriodicalIF":1.5,"publicationDate":"2018-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1715163518797716","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46740455","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Medical legislation for pharmacists: April 1873","authors":"","doi":"10.1177/1715163517750569","DOIUrl":"https://doi.org/10.1177/1715163517750569","url":null,"abstract":"","PeriodicalId":46612,"journal":{"name":"Canadian Pharmacists Journal","volume":"151 1","pages":"8 - 9"},"PeriodicalIF":1.5,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1715163517750569","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"65467044","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"1868 to 2018: 150 years of CPJ","authors":"","doi":"10.1177/1715163517750568","DOIUrl":"https://doi.org/10.1177/1715163517750568","url":null,"abstract":"","PeriodicalId":46612,"journal":{"name":"Canadian Pharmacists Journal","volume":"151 1","pages":"7 - 7"},"PeriodicalIF":1.5,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1715163517750568","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"65467031","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Cover: May 1868","authors":"","doi":"10.1177/1715163517750567","DOIUrl":"https://doi.org/10.1177/1715163517750567","url":null,"abstract":"","PeriodicalId":46612,"journal":{"name":"Canadian Pharmacists Journal","volume":"151 1","pages":"6 - 6"},"PeriodicalIF":1.5,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1715163517750567","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"65467467","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Pharmacy Practice Research Abstracts: Canadian Pharmacists Conference 2017","authors":"","doi":"10.1177/1715163517719855","DOIUrl":"https://doi.org/10.1177/1715163517719855","url":null,"abstract":"","PeriodicalId":46612,"journal":{"name":"Canadian Pharmacists Journal","volume":"150 1","pages":"S1 - S72"},"PeriodicalIF":1.5,"publicationDate":"2017-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1715163517719855","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"49315735","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Hypertension Canada’s 2016 Canadian Hypertension Education Program guidelines for pharmacists","authors":"Yazid N. Al Hamarneh, S. Houle, R. Padwal, R. Tsuyuki","doi":"10.1177/1715163516671747","DOIUrl":"https://doi.org/10.1177/1715163516671747","url":null,"abstract":"The Canadian Hypertension Education Program (CHEP) has been preparing and publishing guidelines for diagnosis and management of hypertension since 1999.1 The 2016 guidelines,2 released earlier this year, mark the 18th yearly production and update of evidence to date in the area of hypertension. Those guidelines, among other Hypertension Canada activities, can be considered as major contributors to the high levels of awareness and control of hypertension in Canada.3,4 Indeed, it has been reported that Canada has higher levels of awareness, treatment and control and lower prevalence of hypertension when compared with the United States and England.3","PeriodicalId":46612,"journal":{"name":"Canadian Pharmacists Journal","volume":"149 1","pages":"337 - 344"},"PeriodicalIF":1.5,"publicationDate":"2016-10-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1715163516671747","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"65467409","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Are selective serotonin reuptake inhibitors associated with fractures?","authors":"Sarah Drost, A. Massicotte","doi":"10.1177/1715163516671744","DOIUrl":"https://doi.org/10.1177/1715163516671744","url":null,"abstract":"Antidepressant use in North America is on the rise. From 2007 to 2011, antidepressants were the most commonly used medication class by Canadian women aged 25 to 79 years and among the top 5 classes of drugs used by men aged 25 to 64 years.1 Selective serotonin reuptake inhibitors (SSRIs; e.g., citalopram, paroxetine, sertraline) are one of the most widely used classes of antidepressants because of their efficacy, favourable side effect profile and broad indications for use.2 \u0000 \u0000In the past decade, more attention has been paid to the adverse effects of medications on bone health. Glucocorticoids, aromatase inhibitors (e.g., anastrazole, letrozole, exemestane), thiazolidinediones or “glitazones” (e.g., pioglitazone) and proton pump inhibitors (e.g., pantoprazole, omeprazole), among others, are suspected contributors to fractures.3 There is evidence indicating that SSRIs may also be implicated.3 In patients aged 66 years and older, current exposure to SSRIs has been associated with hip fractures compared with no antidepressant exposure (adjusted odds ratio [aOR]; 2.4; 95% CI: 2.0-2.7).4 \u0000 \u0000One-third of women and one-fifth of men in Canada will experience an osteoporotic fracture during their lifetime. In 2010, osteoporosis and fractures cost the Canadian health care system upwards of 2.3 billion dollars.5 Fractures can cause a loss of long-term mobility and increase the risk of institutionalization. A prospective observational cohort of older adults showed that 12 months after a hip fracture, only half of patients regained their prefracture mobility level and only one-third of those who were previously mobile without an aid regained full mobility.6 A Canadian cohort (2001-2006) revealed that 12 months after a hip fracture, 24% of adults aged 75 years and older who were previously living in the community required institutionalization.7 However, that risk was much lower in patients aged 60 to 74 years, in whom only 14% of men and 4% of women required a transfer to a long-term care institution.7 Fractures are also associated with mortality, with 28% of women and 37% of men who experience a hip fracture dying within a year.5 It is therefore increasingly important to quantify the association between SSRIs and bone health. This review will discuss the current evidence that explores their association with an increased fracture risk.","PeriodicalId":46612,"journal":{"name":"Canadian Pharmacists Journal","volume":"149 1","pages":"332 - 336"},"PeriodicalIF":1.5,"publicationDate":"2016-10-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1177/1715163516671744","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"65467318","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}